These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36293372)
1. Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells. Ren B; Zhou J; Hu Y; Zhong R; Lv Q; Xie S; Li G; Yang B; Chen X; Zhu Y Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293372 [TBL] [Abstract][Full Text] [Related]
2. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo. Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427 [TBL] [Abstract][Full Text] [Related]
3. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway. Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127 [TBL] [Abstract][Full Text] [Related]
4. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB. Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173 [TBL] [Abstract][Full Text] [Related]
5. T3 Promotes Glioma Cell Senescence and Apoptosis via THRA and THRB. Zhang X; Ma W; Li J; Li C; Liu W; Tang Z; Li L J Environ Pathol Toxicol Oncol; 2021; 40(4):1-9. PubMed ID: 34936295 [TBL] [Abstract][Full Text] [Related]
6. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Dai D; Kumar NS; Wolf DM; Leslie KK Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185 [TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Cao X; Kambe F; Moeller LC; Refetoff S; Seo H Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Zhao S; Chen X; Lu X; Yu Y; Feng Y Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin. Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820 [TBL] [Abstract][Full Text] [Related]
10. RNA-seq and ATAC-seq analysis of CD163 Wang L; Lv Q; Wu P; Luo S; Liu S; Chen X; Luo X Cancer Med; 2023 Mar; 12(5):5964-5978. PubMed ID: 36373483 [TBL] [Abstract][Full Text] [Related]
11. Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism. Hu M; Sun D; Yu J; Fu Y; Qin Z; Huang B; Zhang Q; Chen X; Wei Y; Zhu H; Wang Y; Feng Y; Zheng W; Liao H; Li J; Wu S; Zhang Z Lab Invest; 2022 Dec; 102(12):1335-1345. PubMed ID: 36038734 [TBL] [Abstract][Full Text] [Related]
12. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer. Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735 [TBL] [Abstract][Full Text] [Related]
13. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors. Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565 [TBL] [Abstract][Full Text] [Related]
14. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
15. DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma. Zhou Q; Li W; Kong D; Liu Z; Shi Z; Ma X; Li Y; Jiang J Cancer Med; 2019 Aug; 8(9):4380-4388. PubMed ID: 31215145 [TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. Kenessey A; Ojamaa K J Biol Chem; 2006 Jul; 281(30):20666-20672. PubMed ID: 16717100 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models. Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250 [TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase. Hou X; Arvisais EW; Davis JS Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317 [TBL] [Abstract][Full Text] [Related]
19. MET Inhibits the Proliferation of EC Cells by Increasing MPA Sensitivity. Sun F; Zhou J; Hao Y; Kuang L; Zhang B Altern Ther Health Med; 2023 Jul; 29(5):334-341. PubMed ID: 37171945 [TBL] [Abstract][Full Text] [Related]
20. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression. Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]